Impact of portal vein embolisation uses in colorectal liver metastases: evidence from a rapid review

门静脉栓塞术在结直肠癌肝转移中的应用效果:一项快速综述的证据

阅读:1

Abstract

OBJECTIVES: To compare the short- and long-term outcomes of patients with colorectal liver metastases (CRLM) who underwent portal vein embolisation followed by liver resection (PVEfLR) with those who underwent other treatment strategies. DESIGN: Rapid review of the literature retrieved through a systematic search. DATA SOURCES: Electronic databases PubMed, Embase and Ovid MEDLINE were searched from 1 April 2014 to 31 December 2025. ELIGIBILITY CRITERIA: Studies were included if they involved only patients with CRLM, applied PVEfLR and reported comparative outcomes against other interventions (eg, associating liver partition and portal vein ligation for staged hepatectomy (ALPPS), liver transplantation and portal vein ligation). Only randomised controlled trials, cohort and case-control studies published in English were included. Studies that included patients other than those with CRLM were excluded. DATA EXTRACTION AND SYNTHESIS: Two authors independently screened records, extracted data and assessed quality using the Newcastle-Ottawa Scale. Data were narratively synthesised and presented in summary tables. RESULTS: 14 studies (n=2,022 patients) were included. The overall median survival time for the PVEfLR group was similar to that of the ALPPS group but significantly lower than that of the liver transplantation group (19 vs 41 months, p=0.007). Postoperative complications were significantly lower for PVEfLR than for ALPPS (27% vs 65%, p<0.05) but higher than for liver resection without portal vein embolisation (51% vs 36%, p<0.001). The future liver remnant growth and completion rates for PVEfLR were variable compared with those of other techniques. CONCLUSIONS: PVEfLR is an effective strategy for converting selected patients with initially unresectable CRLM to resectable status, achieving long-term survival comparable to other complex techniques such as ALPPS, although with a different perioperative risk profile. The choice of technique should be individualised based on the patient's anatomy, disease burden and institutional expertise.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。